InfuSystem Holdings, Inc.
- INFU ยท NYSE
- Surgical & Medical Instruments & Apparatus
- Rochester Hills, MI
- 473 employees
- CIK 0001337013
Updated from SEC filings through
Top things to know
Executives
-
Carrie Lachance President and CEO 4, 2026-05-19 -
Barry G. Steele Executive VP and CFO 4, 2026-05-19 - Barry Steele Chief Financial Officer 10-K, 2026-02-27
-
Jerod Funke EVP-Chief HR Officer 4, 2026-05-19 -
Addam Chupa Executive VP and CIO 4, 2026-05-19 -
Beverly Huss Chairman of the Board of Directors 8-K, 2026-05-14
InfuSystem Holdings, Inc is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Rochester Hills, MI. It trades as INFU on NYSE. Revenue was $143M in the fiscal year ending December 31, 2025, +6.4% from the year before. It reported about 473 employees. Carrie Lachance is President and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $143M 10-K, 2026-02-27 | $135M 10-K, 2026-02-27 | $126M 10-K, 2025-03-11 | $110M 10-K, 2024-04-10 | $102M 10-K, 2024-04-10 |
| Operating income | $11.9M 10-K, 2026-02-27 | $6.9M 10-K, 2026-02-27 | $4.1M 10-K, 2025-03-11 | $1.7M 10-K, 2024-04-10 | $2.8M 10-K, 2024-04-10 |
| SG&A | $67.5M 10-K, 2026-02-27 | $62.5M 10-K, 2026-02-27 | $58.0M 10-K, 2025-03-11 | $56.4M 10-K, 2024-04-10 | $51.5M 10-K, 2024-04-10 |
| Net income | $6.6M 10-K, 2026-02-27 | $2.3M 10-K, 2026-02-27 | $872K 10-K, 2025-03-11 | $18K 10-K, 2024-04-10 | $1.4M 10-K, 2024-04-10 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Carrie Lachance President & CEO at InfuSystem | President and CEO | 4, 2026-05-19 |
| Richard DiIorio | Named in proxy bio: Former Chief Executive Officer | DEF 14A, 2026-04-10 |
| Barry G. Steele | Executive VP and CFO | 4, 2026-05-19 |
| Barry Steele | Chief Financial Officer | 10-K, 2026-02-27 |
| Jerod Funke EVP, Chief Human Resources Officer, Infusystem | EVP-Chief HR Officer | 4, 2026-05-19 |
| Addam Chupa Executive Vice President & Chief Information Officer | Executive VP and CIO | 4, 2026-05-19 |
| Beverly Huss | Chairman of the Board of Directors | 8-K, 2026-05-14 |
| Beverly A. Huss | Board member (per proxy) bio: Director | DEF 14A, 2026-04-10 |
| John Sviokla | Board member (per proxy) bio: Director | DEF 14A, 2026-04-10 |
| Kenneth D. Eichenbaum, MD, MSE | Board member (per proxy) bio: Director | DEF 14A, 2026-04-10 |
| Paul A. Gendron | Board member (per proxy) bio: Director | DEF 14A, 2026-04-10 |
 Ronald Hundzinski | Director | 10-K, 2026-02-27 |
| Scott Shuda | Chairman of the Board | 10-K, 2026-02-27 |
| John J. Sviokla | Director | 10-K, 2026-02-27 |
| Kenneth Eichenbaum | Director | 10-K, 2026-02-27 |
| Paul Gendron | Director | 10-K, 2026-02-27 |
What InfuSystem Holdings, Inc does
InfuSystem Holdings, Inc. ("we," "us," "our" or the "Company") is a Delaware corporation., a Delaware corporation ("InfuSystem" or "ISI").
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 20.0 million (as of November 8, 2026) | 10-Q, November 9, 2026 |
|---|---|---|
| Public float | $122M (as of June 30, 2025) | 10-K, February 27, 2026 |
| Reportable segments | 2 (period ending September 30, 2026) | 10-Q, November 9, 2026 |
| Latest proxy statement | Meeting April 10, 2026 (filed April 10, 2026) | DEF 14A, April 10, 2026 |
| Auditor | Deloitte & Touche LLP (Detroit, Michigan) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| May 11, 2026 | Carrie Lachance President and CEO | Buy | 3,000 | $26K | Form 4, May 12, 2026 |
| May 8, 2026 | Paul Andrew Gendron Director | Buy | 5,000 | $44K | Form 4, May 12, 2026 |
| May 8, 2026 | Barry G. Steele Executive VP and CFO | Buy | 7,000 | $61K | Form 4, May 12, 2026 |
| March 2, 2026 | Barry G. Steele Executive VP and CFO | Buy | 2,064 | $19K | Form 4, March 2, 2026 |
| August 22, 2025 | Scott Shuda Director | Sale | 5,752 | $56K | Form 4, August 22, 2025 |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-11-03
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-27
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-17
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-04
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-28
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-18
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-14
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-12
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
Frequently asked questions about InfuSystem Holdings, Inc
- What does InfuSystem Holdings, Inc do?
- In its own words, from Item 1 of its 10-K: "InfuSystem Holdings, Inc. ("we," "us," "our" or the "Company") is a Delaware corporation., a Delaware corporation ("InfuSystem" or "ISI")."
- What is InfuSystem Holdings, Inc's revenue?
- $143M for the fiscal year ending December 31, 2025, from its 10-K filed February 27, 2026.
- Is InfuSystem Holdings, Inc profitable?
- InfuSystem Holdings, Inc reported net income of $6.6M for the fiscal year ending December 31, 2025.
- How many employees does InfuSystem Holdings, Inc have?
- About 473 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of InfuSystem Holdings, Inc?
- Carrie Lachance, President and CEO, as named in a 4 filed May 19, 2026.
- Who is the CFO of InfuSystem Holdings, Inc?
- Barry G. Steele, Executive VP and CFO, as named in a 4 filed May 19, 2026.
- Where is InfuSystem Holdings, Inc headquartered?
- Rochester Hills, MI.
- What is InfuSystem Holdings, Inc's stock ticker?
- INFU on NYSE.
- What industry is InfuSystem Holdings, Inc in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is InfuSystem Holdings, Inc's website?
- infusystem.com.
- When does InfuSystem Holdings, Inc report earnings next?
- November 10, 2026 at 09:00. Source: sec_8k.
- Is InfuSystem Holdings, Inc a public company?
- Yes. InfuSystem Holdings, Inc files with the SEC under CIK 0001337013 and trades as INFU.
- Who audits InfuSystem Holdings, Inc?
- Deloitte & Touche LLP, Detroit, Michigan, as named in its latest annual report (10-K).
- How many shares of InfuSystem Holdings, Inc are outstanding?
- 20.0 million shares as of November 8, 2026, from its 10-Q filed November 9, 2026.
- What is InfuSystem Holdings, Inc's public float?
- $122M as of June 30, 2025, as reported on the cover of its 10-K filed February 27, 2026.
- How many business segments does InfuSystem Holdings, Inc report?
- 2 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 9, 2026.
- When is InfuSystem Holdings, Inc's annual shareholder meeting?
- April 10, 2026, per its proxy statement (DEF 14A) filed April 10, 2026.
- Have InfuSystem Holdings, Inc insiders traded stock recently?
- Since August 22, 2025, officers and directors reported 1 open-market sale worth about $56K and 4 purchases worth about $150K on Forms 4 and 5. The most recent: Carrie Lachance (President and CEO) bought 3,000 shares on May 11, 2026.